New Business For Sale: Compounding Pharmacy - LA County

Home / Blog / New Business For Sale: Compounding Pharmacy - LA County

The Biz Blog

March 25, 2017 by Tom Plotkin

Tom Plotkin just launched a new listing: Compounding Pharmacy - LA County

Compounding Pharmacy - LA County
Asking: $695,000 • Gross: $703,260 • Net: $270,519

Highly profitable Sterile and non-Sterile Compounding Pharmacy for sale.  The pharmacy is ideally situated in a Medical Plaza in the northwestern section of Los Angeles County.  There are at least 10 doctors in the building who work with the pharmacy

Points of Interest:

Computer Software: Digital Rx

Computer Hardware: Hp (2) and POS System

Top Ten Drugs: Lidocaine 5%, Morphine 100 mg/20 mL oral solution, Norco 5/325, Norco 10/325, Eliquis, Lantus, Humalog, Lovenox 40 mg/mL, Ondansertron 4mg ODT & Suboxone

Wholesalers: HD Smith, Valley Wholesale & Trimed

Insurances: All insurance plans except straight Medi-Cal and Cigna. Arete is the Third Party Network.

 

For more information, please visit BizEx.net to complete the online Buyer Registration & N.D.A. Contact: Tom Plotkin at 310.882.2200 x 127 - tplotkin@bizex.net - Lic#: 01895229

 

 

 

Tom Plotkin
Email: tplotkin@bizex.net
Office: (310) 882-2200 ext 127
Blog: https://www.bizex.net/blog
Web: https://www.bizex.net/business-broker-ma-advisor/tom-plotkin

Businesses for Sale



Broker Information



Tom Plotkin

4640 Admiralty Way, Suite 500
Marina Del Rey, CA 90292
Office: (310) 882-2200 ext 127
Direct: (818) 585-4215
Lic#: 01895229

Contact
Logos Member of the California Association of Business Brokers Member of the International Business Brokers Association Member of the M&A Source Holder of the Merger & Acquisition Master Intermediary designation, M&A Source's highest qualification Holder of the Certified Business Intermediary designation, IBBA's highest qualification Holder of the Certified M&A Professional designation from Coles College Trained by the National Association of Certified Valuators and Analysts to conduct business valuations